Aurora Cannabis Inc., the Canadian company opening the world to cannabis, today announced the launch of a new tracking program designed to support and empower cannabis patients on their wellness journey.
Alongside the advice of a healthcare professional, Aurora patients can use the award-winning Strainprint® App journal to track their medical cannabis journey by logging their symptoms and consumption habits to better understand which strains, THC and CBD levels, ingestion methods and doses best work for them. Patients can also explore new products, learn more about strains and understand what has helped other patients through the App. All data entered and gathered by the Strainprint App is anonymous and aggregated.
“We take a patient-first approach to cannabis and are proud to provide our patients with programs that improve their lives and their medical cannabis journey,” says Mike Jones, SVP of Medical at Aurora Cannabis. “By working with Strainprint, we can support our patients every step of the way, and further Aurora’s promise to prioritize patient well-being and provide the highest quality products.”
Patients can download the free Strainprint App on the Apple Store and Google Play Store.
About Strainprint
Based in Toronto, Canada, Strainprint® Technologies is the leading data and analytics technology platform for medical and recreational cannabis use research. With over 2.1 million real-time user-interactions logged against 9,500+ legal and lab-tested cannabis products on the Strainprint® platform (over 100 million data points), Strainprint® is also the most extensive real-world evidence (RWE) study on therapeutic cannabis use and its impact on over 300 therapeutic conditions and symptoms – Cannabis Big Data®! www.strainprint.ca, facebook, twitter, linkedin.
About Aurora
Aurora is opening the world to cannabis, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. as well as international brands, Pedanios, Bidiol and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America’s leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn.
